Literature DB >> 6888561

Amplified DNA with limited homology to myc cellular oncogene is shared by human neuroblastoma cell lines and a neuroblastoma tumour.

M Schwab, K Alitalo, K H Klempnauer, H E Varmus, J M Bishop, F Gilbert, G Brodeur, M Goldstein, J Trent.   

Abstract

Amplified cellular genes in mammalian cells frequently manifest themselves as double minute chromosomes (DMs) and homogeneously staining regions of chromosomes (HSRs). With few exceptions both karyotypic abnormalities appear to be confined to tumour cells. All vertebrates possess a set of cellular genes homologous to the transforming genes of RNA tumour viruses, and there is circumstantial evidence that these cellular oncogenes are involved in tumorigenesis. We have recently shown that DMs and HSRs in cells of the mouse adrenocortical tumour Y1 and an HSR in the human colon carcinoma COLO320 contain amplified copies of the cellular oncogenes c-Ki-ras and c-myc, respectively. Both DMs and HSRs are found with remarkable frequency in cells of human neuroblastomas. We show here that a DNA domain detectable by partial homology to the myc oncogene is amplified up to 140-fold in cell lines derived from different human neuroblastomas and in a neuroblastoma tumour, but not in other tumour cells showing cytological evidence for gene amplification. By in situ hybridization we found that HSRs are the chromosomal sites of the amplified DNA. The frequency with which this amplification appears in cells from neuroblastomas and its apparent specificity raise the possibility that one or more of the genes contained within the amplified domain contribute to tumorigenesis.

Entities:  

Mesh:

Year:  1983        PMID: 6888561     DOI: 10.1038/305245a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  376 in total

Review 1.  Diagnosis and classification of the small round-cell tumors of childhood.

Authors:  S L Cohn
Journal:  Am J Pathol       Date:  1999-07       Impact factor: 4.307

Review 2.  Demystified ... oncogenes.

Authors:  Y L Wallis; F Macdonald
Journal:  Mol Pathol       Date:  1999-04

3.  Lack of homozygously inactivated p73 in single-copy MYCN primary neuroblastomas and neuroblastoma cell lines.

Authors:  X T Kong; V A Valentine; S T Rowe; M B Valentine; S T Ragsdale; B G Jones; D A Wilkinson; G M Brodeur; S L Cohn; A T Look
Journal:  Neoplasia       Date:  1999-04       Impact factor: 5.715

4.  Insertional activation of N-myc by endogenous Moloney-like murine retrovirus sequences in macrophage cell lines derived from myeloma cell line-macrophage hybrids.

Authors:  M Setoguchi; Y Higuchi; S Yoshida; N Nasu; Y Miyazaki; S Akizuki; S Yamamoto
Journal:  Mol Cell Biol       Date:  1989-10       Impact factor: 4.272

5.  Selection of cells with different chromosomal localizations of the amplified c-myc gene during in vivo and in vitro growth of the breast carcinoma cell line SW 613-S.

Authors:  D Cherif; C Lavialle; N Modjtahedi; M Le Coniat; R Berger; O Brison
Journal:  Chromosoma       Date:  1989-01       Impact factor: 4.316

6.  Nucleotide sequence of the human N-myc gene.

Authors:  L W Stanton; M Schwab; J M Bishop
Journal:  Proc Natl Acad Sci U S A       Date:  1986-03       Impact factor: 11.205

7.  Human small-cell lung cancers show amplification and expression of the N-myc gene.

Authors:  M M Nau; B J Brooks; D N Carney; A F Gazdar; J F Battey; E A Sausville; J D Minna
Journal:  Proc Natl Acad Sci U S A       Date:  1986-02       Impact factor: 11.205

8.  Malignant phenotype correlating with drug resistance in two human neuroblastoma cell lines.

Authors:  Y Wollman; I Shahar; M Goldstein; J Leibovici
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

9.  Myc and Max: molecular evolution of a family of proto-oncogene products and their dimerization partner.

Authors:  W R Atchley; W M Fitch
Journal:  Proc Natl Acad Sci U S A       Date:  1995-10-24       Impact factor: 11.205

10.  Detection of N-myc gene amplification by fluorescence in situ hybridization. Diagnostic utility for neuroblastoma.

Authors:  D N Shapiro; M B Valentine; S T Rowe; A E Sinclair; J E Sublett; W M Roberts; A T Look
Journal:  Am J Pathol       Date:  1993-05       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.